CSTL Castle Biosciences, Inc.
Healthcare$20.15-1.90%ClosedMarket Cap: $611.1M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$47.80
Target (Median)
$50.00
Target Range
$40.00 - $52.00
Upside from current price: 137.2%
Rating Distribution
0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | BTIG | maintain | Buy | Buy |
| 2026-05-07 | Baird | maintain | Outperform | Outperform |
| 2026-04-20 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-02-27 | Baird | maintain | Outperform | Outperform |
| 2026-01-26 | Guggenheim | maintain | Buy | Buy |
| 2026-01-12 | Lake Street | maintain | Buy | Buy |
| 2025-12-22 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-12-12 | BTIG | maintain | Buy | Buy |
| 2025-11-05 | BTIG | maintain | Buy | Buy |
| 2025-11-04 | Baird | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.90 | $392.9M | 5 |
| Sun Dec 31 | $-0.50 | $434.5M | 5 |
| Mon Dec 31 | $0.32 | $469.7M | 1 |
| Tue Dec 31 | $0.74 | $507.9M | 1 |